82 FR 20895 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 85 (May 4, 2017)

[Federal Register Volume 82, Number 85 (Thursday, May 4, 2017)]
[Notices]
[Page 20895]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09015]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement, RFA-TS17-
001, Identify and Characterize Potential Environmental Risk Factors for 
Amyotrophic Lateral Sclerosis (ALS).
    Time and Date: 8:00 a.m.-5:00 p.m., EDT, May 31, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Identify and Characterize Potential Environmental Risk Factors for 
ALS'', RFA-TS-17-001.
    Contact Person for More Information: Oscar Tarrago, M.D., M.P.H., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, 
Atlanta, Georgia 30341-3724, Telephone: (770) 488-3492.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-09015 Filed 5-3-17; 8:45 am]
 BILLING CODE 4163-18-P